Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...

Ozempic and its weight-loss cousin, Wegovy, outperform another longstanding weight-loss drug that targets the same ho ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss ... pill led to an average weight loss of 15% over 68 weeks, a similar result as seen in trials of Wegovy.

Discover the weight loss benefits of semaglutide and liraglutide for obese patients. Cleveland Clinic study examines Wegovy, Ozempic, Saxenda and Victoza.

Nearly 4.4 million adult New Yorkers, or 30%, has obesity, but access to weight-loss medications varies based on a variety of ...